Managing alcohol withdrawal in the elderly
- PMID: 10408740
- DOI: 10.2165/00002512-199914060-00002
Managing alcohol withdrawal in the elderly
Abstract
The alcohol withdrawal syndrome is common in elderly individuals who are alcohol dependent and who decrease or stop their alcohol intake. While there have been few clinical studies to directly support or refute the hypothesis that withdrawal symptom severity, delirium and seizures increase with advancing age, several observational studies suggest that adverse functional and cognitive complications during alcohol withdrawal do occur more frequently in elderly patients. Most elderly patients with alcohol withdrawal symptoms should be considered for admission to an inpatient setting for supportive care and management. However, elderly patients with adequate social support and without significant withdrawal symptoms at presentation, comorbid illness or past history of complicated withdrawal may be suitable for outpatient management. Although over 100 drugs have been described for alcohol withdrawal treatment, there have been no studies assessing the efficacy of these drugs specifically in elderly patients. Studies in younger patients support benzodiazepines as the most efficacious therapy for reducing withdrawal symptoms and the incidence of delirium and seizure. While short-acting benzodiazepines, such as oxazepam and lorazepam, may be appropriate for elderly patients given the risk for excessive sedation from long-acting benzodiazepines, they may be less effective in preventing seizures and more prone to produce discontinuation symptoms if not tapered properly. To ensure appropriate benzodiazepine treatment, dose and frequency should be individualised with frequent monitoring, and based on validated alcohol withdrawal severity measures. Selected patients who have a history of severe or complicated withdrawal symptoms may benefit from a fixed schedule of benzodiazepine provided that medication is held for sedation. beta-Blockers, clonidine, carbamazepine and haloperidol may be used as adjunctive agents to treat symptoms not controlled by benzodiazepines. Lastly, the age of the patient should not deter clinicians from helping the patient achieve successful alcohol treatment and rehabilitation.
Similar articles
-
Alcohol withdrawal syndrome: how to predict, prevent, diagnose and treat it.Prescrire Int. 2007 Feb;16(87):24-31. Prescrire Int. 2007. PMID: 17323538
-
Pharmacotherapies for alcohol abuse. Withdrawal and treatment.Med Clin North Am. 1997 Jul;81(4):881-907. doi: 10.1016/s0025-7125(05)70554-x. Med Clin North Am. 1997. PMID: 9222259 Review.
-
Inpatient management of acute alcohol withdrawal syndrome.CNS Drugs. 2014 May;28(5):401-10. doi: 10.1007/s40263-014-0163-5. CNS Drugs. 2014. PMID: 24781751
-
Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal.JAMA. 1997 Jul 9;278(2):144-51. doi: 10.1001/jama.278.2.144. JAMA. 1997. PMID: 9214531
-
Symptom-Triggered Therapy for Alcohol Withdrawal Syndrome: a Systematic Review and Meta-analysis of Randomized Controlled Trials.J Gen Intern Med. 2019 Jun;34(6):1018-1024. doi: 10.1007/s11606-019-04899-7. Epub 2019 Apr 1. J Gen Intern Med. 2019. PMID: 30937668 Free PMC article.
Cited by
-
Drug Safety Profiles of Geriatric Patients Referred to Consultation Psychiatry in the Emergency Department-A Retrospective Cohort Study.J Geriatr Psychiatry Neurol. 2023 Sep;36(5):407-416. doi: 10.1177/08919887221149158. Epub 2023 Jan 2. J Geriatr Psychiatry Neurol. 2023. PMID: 36592403 Free PMC article.
-
A multidisciplinary approach to the management of liver disease and alcohol disorders in psychiatric settings (Review).Exp Ther Med. 2021 Mar;21(3):271. doi: 10.3892/etm.2021.9702. Epub 2021 Jan 25. Exp Ther Med. 2021. PMID: 33603878 Free PMC article. Review.
-
Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management.CNS Drugs. 2003;17(14):1013-30. doi: 10.2165/00023210-200317140-00002. CNS Drugs. 2003. PMID: 14594442 Review.
-
Potentially inappropriate medications according to PRISCUS list and FORTA (Fit fOR The Aged) classification in geriatric psychiatry: a cross-sectional study.J Neural Transm (Vienna). 2022 Nov;129(11):1367-1375. doi: 10.1007/s00702-022-02541-1. Epub 2022 Sep 2. J Neural Transm (Vienna). 2022. PMID: 36050603 Free PMC article.
-
Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm.Drugs. 2012 Oct 1;72(14):1881-916. doi: 10.2165/11636220-000000000-00000. Drugs. 2012. PMID: 22950534 Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous